Article Information
- Received November 22, 2022
- Revision received May 24, 2023
- Accepted June 5, 2023
- First published June 8, 2023.
- Version of record published July 5, 2023.
Author Information
Author contributions
Author contributions: W.F.T. and M.C.W. designed research; W.F.T. performed research; W.F.T. analyzed data; W.F.T. and M.C.W. wrote the paper.
Disclosures
- Received November 22, 2022.
- Revision received May 24, 2023.
- Accepted June 5, 2023.
This work was supported by an American Epilepsy Society fellowship (W.F.T.) and National Institutes of Health Grants R01 NS110945 and NS130042 (to M.C.W.). We thank Todd Clason for his assistance with imaging equipment; Dr. Matt Mahoney for assistance with statistics, data analysis, and coding; Dr. Amy Shore for help with genotyping and manuscript editing; the Vermont Advanced Computing Center; members of the Weston lab and ECD group at the Univeristy of Vermont for their feedback; and Wayne Frankel and his group at Colombia for the Kcnt1 Y777H mouse line.
The authors declare no competing financial interests.
- Correspondence should be addressed to Matthew C. Weston at mcweston7c{at}vtc.vt.edu
Funding
HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
American Epilepsy Society (AES)
Other Version
- previous version (June 08, 2023).
- You are viewing the most recent version of this article.
